We are live on ! Find out more
VTAK icon

Catheter Precision

12 hedge funds and large institutions have $120K invested in Catheter Precision in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

20% more funds holding

Funds holding: 1012 (+2)

0.18% less ownership

Funds ownership: 0.39%0.21% (-0.18%)

41% less capital invested

Capital invested by funds: $202K → $120K (-$82.1K)

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q2 2025 in Review

12 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2025, worth a combined $120K — down 41% from $202K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VTAK positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $49.5K. The largest seller was Armistice Capital, exiting entirely with an estimated $86.3K sold.

  • 12 institutional investors held Catheter Precision (VTAK) as of Q2 2025, up from 10 in Q1 2025.
  • Funds reported $120K of Catheter Precision stock for Q2 2025, down 41% quarter-over-quarter.
  • 6 funds opened new Catheter Precision positions in Q2 2025 and 4 closed out, a net change of +2 holders.
  • The largest Catheter Precision buyer in Q2 2025 was HRT Financial, an estimated $49.5K added.
  • The largest Catheter Precision seller in Q2 2025 was Armistice Capital, an estimated $86.3K sold.

Based on aggregated 13F filings for Q2 2025.